PegfilgrastimTumour lysis-like syndrome and leukocytosis: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1919卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21429-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：487 / 487

相关论文

共 50 条

[31] HydroxycarbamideTumour lysis syndrome: case report [J].

Reactions Weekly, 2021, 1863 (1) :180-180

[32] VenetoclaxTumour lysis syndrome: case report [J].

Reactions Weekly, 2020, 1787 (1) :478-478

[33] AntineoplasticsTumour lysis syndrome: case report [J].

Reactions Weekly, 2010, 1307 (1) :13-13

[34] AntineoplasticsTumour lysis syndrome: case report [J].

Reactions Weekly, 2019, 1735 (1) :38-38

[35] RuxolitinibTumour lysis syndrome: case report [J].

Reactions Weekly, 2017, 1671 (1) :347-347

[36] CytarabineTumour lysis syndrome: case report [J].

Reactions Weekly, 2016, 1589 (1) :76-76

[37] AtezolizumabTumour lysis syndrome: case report [J].

Reactions Weekly, 2019, 1769 (1) :74-74

[38] ImatinibTumour lysis syndrome: case report [J].

Reactions Weekly, 2009, 1238 (1) :18-18

[39] CrizotinibTumour lysis syndrome: case report [J].

Reactions Weekly, 2017, 1660 (1) :123-123

[40] IpilimumabTumour lysis syndrome: case report [J].

Reactions Weekly, 2017, 1644 (1) :167-167

← 1 2 3 4 5 →